These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22992564)

  • 1. Specific immunoglobulin against hepatitis C virus. Why not?
    Piazza M
    Infez Med; 2012 Sep; 20(3):214-6. PubMed ID: 22992564
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vitro Neutralization Assay Using Cultured Hepatitis C Virus.
    Prentoe J; Bukh J
    Methods Mol Biol; 2019; 1911():433-439. PubMed ID: 30593643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).
    Bailey JR; Urbanowicz RA; Ball JK; Law M; Foung SKH
    Methods Mol Biol; 2019; 1911():441-450. PubMed ID: 30593644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.
    Li D; Wang X; von Schaewen M; Tao W; Zhang Y; Heller B; Hrebikova G; Deng Q; Sun Q; Ploss A; Zhong J; Huang Z
    J Infect Dis; 2017 Jun; 215(12):1824-1831. PubMed ID: 28398489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virus.
    Abdel Malak CA; Abelhafez TH; Tabll AA; Mashaly MM; El Shenawy R; El-Abd YS; Shaker MH; El-Awady MK
    Hum Antibodies; 2017; 26(3):127-134. PubMed ID: 29036810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
    Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
    Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.
    Yu MY; Bartosch B; Zhang P; Guo ZP; Renzi PM; Shen LM; Granier C; Feinstone SM; Cosset FL; Purcell RH
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7705-10. PubMed ID: 15136748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus plays hide and seek with neutralizing antibodies.
    Bankwitz D; Pietschmann T
    Hepatology; 2016 Dec; 64(6):1840-1842. PubMed ID: 27515101
    [No Abstract]   [Full Text] [Related]  

  • 10. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
    Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J
    J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C cross-genotype immunity and implications for vaccine development.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Wong J; Tyndall MW; Janjua NZ;
    Sci Rep; 2017 Sep; 7(1):12326. PubMed ID: 28951612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of immune serum globulin following exposure to hepatitis C virus.
    Miller MA; Orenstein P; Amihod B
    Clin Infect Dis; 1993 Feb; 16(2):335. PubMed ID: 7680238
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization.
    Zibert A; Dudziak P; Schreier E; Roggendorf M
    Arch Virol; 1997; 142(3):523-34. PubMed ID: 9349298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
    Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
    New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
    Christiansen D; Earnest-Silveira L; Chua B; Boo I; Drummer HE; Grubor-Bauk B; Gowans EJ; Jackson DC; Torresi J
    Viral Immunol; 2018 May; 31(4):338-343. PubMed ID: 29489437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
    Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
    PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
    Sasayama M; Shoji I; Adianti M; Jiang DP; Deng L; Saito T; Watanabe H; Kawata S; Aoki C; Hotta H
    J Med Virol; 2012 Feb; 84(2):229-34. PubMed ID: 22170542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-associated hepatitis C virus in cell cultures and patient plasma.
    Liu Z; Zhang X; Yu Q; He JJ
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):218-22. PubMed ID: 25449270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.